We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Different Methods Compared for Species Identification of Enterococcus

By LabMedica International staff writers
Posted on 18 May 2020
Biochemical test‐based methodologies are still used in some laboratories for the identification of bacterial isolates, mainly because of the need for the performance of drug susceptibility tests. More...
However, these systems are unable to distinguish some species, especially among Gram‐positive bacteria.

Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) is an efficient method used in clinical microbiology laboratories for the identification of clinically relevant microorganisms. Microorganisms can be identified using a reference database in a turnaround time of minutes, which is essential when rapid results are needed.

Medical Scientists at the Universidad Autónoma de Nuevo León (Monterrey, Mexico) evaluated the performance of two commercial MALDI‐TOF MS systems and three biochemical‐based systems and compared them to whole genome sequencing (WGS) as the gold standard for identifying isolates of vancomycin‐resistant enterococci (VRE). A total of 87 VRE clinical isolates recovered from urine (33%), soft tissue (24%), blood (16%), and other specimens (27%) were identified by the systems.

For both MALDI‐TOF instruments, the direct method was used for identification. The mass spectrometers were the Microflex system with Biotyper software 3.1 (Biotyper; Bruker Daltonics, Bremen, Germany) and the Vitek MS system (bioMérieux, Marcy l'Etoile, France). The biochemical‐based systems included the bioMérieux Vitek 2, Phoenix (Becton‐Dickinson, Franklin Lakes, NJ, USA), and MicroScan WalkAway (Siemens Healthcare Diagnostics, Munich, Germany) systems. Paired‐end sequencing runs were performed on an Illumina MiSeq instrument (Illumina, San Diego, CA, USA).

The scientists reported that among the 87 VRE, 71 and 16 were identified as Enterococcus faecium and Enterococcus faecalis by WGS. All 71 E. faecium were correctly identified by both mass spectrometers, as well as the Vitek 2 and Phoenix instruments. However, only 51 E. faecium isolates were correctly identified by the MicroScan system. The most frequent misidentification was Enterococcus casseliflavus (n = 20). For vancomycin‐resistant E. faecium, the Microflex Biotyper system had the highest sensitivity (85.54%), and all instruments (except for the MicroScan) had a 100% specificity and positive predictive value (PPV). Up to 87% of E. faecalis isolates were misidentified by VITEK MS and VITEK2, 81% by MicroScan and Phoenix, and 75% by Bruker biotyper. The NPV was lower than 38% for all devices. The instrument with the highest accuracy was the Bruker Biotyper system (86.21%).

The authors concluded that as the coverage of type strain‐genome sequence database continues to grow and the cost of DNA sequencing continues to decrease, genome‐based identification can be a useful tool for diagnostic laboratories, with its superior accuracy even over MALDI‐TOF and database‐driven operations. The study was published on May 1, 2020 in the Journal of Clinical Laboratory Analysis.




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.